Pharmacological therapy remains central in ASCVD management. Statinsalong with ezetimibe, bempedoic acid and PCSK9 inhibitorscontinue to drive effective LDL cholesterol reduction and cardiovascular risk prevention. Growing focus is now on residual Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS NEW Biote BPC 157 + KPV Health Horizons USA BPC 157 Peptide for Tissue Repair & Recovery ElixerMD